Critical illnesses have a significant impact on overall survival among patients with cancer
the ONA take:
A new study from researchers at the University of Glasgow found 1 in 20 patients with cancer were admitted to the intensive care unit (ICU) for a critical illness within 2 years of their diagnosis, and a quarter of them died in hospital. In addition, this risk increased with age.
Using cancer registry and hospital data from Scotland spanning 10 years, the researchers captured information on more than 118,500 people with cancer, including 6,116 who were admitted to ICU.
Study findings showed that risk of ICU admission was highest among patients with GI cancer and lowest in patients with prostate cancer, breast cancer, and melanoma of the skin.
Mortality was higher among emergency medical admissions, and those who received organ support compared with those who did not receive organ support.
Deaths during hospital stays was higher among patients with cancers of unknown primary cause, lung cancer, and liver cancer, but those with head and neck cancers, multiple cancers, kidney cancer, and thyroid cancer had lower mortality rates.
The study indicates that critical illness may play a role in overall cancer outcomes. The researchers suggest that if ICUs can effectively reduce the risk of dying following a critical illness, increased surveillance for early signs of critical illness and access to ICU care for patients with cancer may improve overall survival rates.
1 in 20 patients with cancer were admitted to the intensive care unit (ICU) for a critical illness within 2 years of their diagnosis.
Sign Up for Free e-newsletters
- Hodgkin Lymphoma Survivorship Marked by Periods of Actionable Distress
- Dose-Escalation Mitigates Risk of Grade 3/4 Adverse Events With Ruxolitinib for Myelofibrosis
- Stem Cell Transplantation Superior to Chemotherapy for Relapsed/Refractory DLBCL, Follicular Lymphoma
- Patients and Caregivers Worry About Cost of Cancer Care
- Integrative Medicine in Childhood Cancer: Practices That Can Help Pediatric Patients
- Navigating Prostate Cancer: A Patient's Experience From Diagnosis to Survivor
- Cell Phones and Cancer Risk (Fact Sheet)
- How Likely Are Oncologists to Refer for Palliative Care? Depends on Their Age
- Chemoimmunotherapy Increases Survival in Triple-Negative Breast Cancer
- Seeking an Explanation for the Lack of Research Focused in Pediatric Oncology Therapeutics
- Risk for Colon Cancer, Osteogenic Sarcoma Higher With Presence of Diamond-Blackfan Anemia
- G-CSF Support Increases Overall Survival, But Risk of Secondary Malignancies Also Higher
- Report From Childhood Cancer Survivor Study Identifies Long-Term Risks for VTE
- The Effect of Intravenous Hydration Strategy on Plasma Methotrexate Clearance During Intravenous High-dose Methotrexate Administration in Pediatric Oncology Patients
- Outcomes Worse for Minimally Invasive Hysterectomy vs Open Surgery
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|